Ann: Leading US-based nerve surgeons appointed to advisory board, page-23

What I also like if the cut of this gentleman's cloth!

https://www.prnewswire.com/news-releases/christopher-j-dy-md-faaos-named-2023-kappa-delta-young-investigator-award-winner-301743769.html

This is a guy who genuinely care about outcomes and ongoing quality of life in patients lives. I couldn't believe the almost indifference the Aussie public met the news of the Remplir's efficacy in nerve grafts in paraplegic patients. I think if the same story kicked off in the US it would run and run, as would company coverage of course. Orthocell was barely mentioned in some of Aussie coverage. More the surgeons/research institute involved.

Remplir and ATI are eventually going to make a lot of difference to people's quality of lives globally hopefully. Its been a horrible slog investing in OCC, but I am investing in something very humane. Easy to lose sight of that with the share price.